EU boosts Pfizer vaccine supply with German site approvals
Both approved sites are located in Germany. One of them is operated by Sanofi-Aventis Deutschland Gmb and the other is operated by Siegfried Hameln GmbH, the European Medicines Agency said
FILE PHOTO: Vials labelled "COVID-19 Coronavirus Vaccine" and a syringe are seen in front of the Pfizer logo in this illustration taken February 9, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
The European Union's drugs regulator on Thursday approved an increase in manufacturing capacity for the Covid-19 vaccine from Pfizer/BioNTech , which would help produce up to 50 million additional doses this year.
Both approved sites are located in Germany.
One of them is operated by Sanofi-Aventis Deutschland Gmb and the other is operated by Siegfried Hameln GmbH, the European Medicines Agency said.
Keep updated, follow The Business Standard's Google news channel
